| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 06/03/2010 | US20100136005 Method of Treatment Using Humanized Anti-CD11a Antibodies |
| 06/03/2010 | US20100136003 Uses of mammalian cytokine; related reagents |
| 06/03/2010 | US20100136002 Methods for treating and preventing multiple sclerosis |
| 06/03/2010 | US20100135997 Polypeptide monomers and dimers containing mutated ilt |
| 06/03/2010 | US20100135996 Monoclonal antibodies and fragment thereof directed against the human anti-mullerian hormone type ii receptor (amhr-ii) |
| 06/03/2010 | US20100135994 Hiv vaccine based on targeting maximized gag and nef to dendritic cells |
| 06/03/2010 | US20100135991 Antibodies recognizing oxygen-regulated protein 150 expressed on cancer cells and methods of using same |
| 06/03/2010 | US20100135989 Anti-hiv agents |
| 06/03/2010 | US20100135985 Genes involved in the regulation of angiogenesis, pharmaceutical preparations containing them an uses thereof |
| 06/03/2010 | US20100135974 Redirected, genetically-engineered t regulatory cells and their use in suppression of autoimmune and inflammatory disease |
| 06/03/2010 | US20100135957 Chimeric Heteromultimer Adhesins |
| 06/03/2010 | US20100135955 HUMAN M2e PEPTIDE IMMUNOGENS |
| 06/03/2010 | US20100135948 Anti-Autoimmune Antibodies for Treatment of Pemphigus |
| 06/03/2010 | US20100135910 Modulation of Anergy and Methods for Isolating Anergy-Modulating Compounds |
| 06/03/2010 | US20100135904 Compositions and methods for the inhibition of cripto / grp78 complex formation and signaling |
| 06/03/2010 | CA2744588A1 Ligands that bind il-13 |
| 06/03/2010 | CA2744384A1 Nanoaggregate embedded beads conjugated to single domain antibodies |
| 06/03/2010 | CA2744344A1 Antibody-targeted carrier for contrast agents |
| 06/03/2010 | CA2744055A1 Polypeptides, antibody variable domains & antagonists |
| 06/03/2010 | CA2741566A1 Inflammatory bowel disease biomarkers and related methods of treatment |
| 06/03/2010 | CA2740900A1 Antibodies that specifically block the biological activity of a tumor antigen |
| 06/02/2010 | EP2192188A1 Anti-met monoclonal antibody, fragments and vectors thereof, for the treatment of tumors and corresponding products |
| 06/02/2010 | EP2192184A1 Detection of bacterium belonging to genus campylobacter which targets cytolethal distending toxin |
| 06/02/2010 | EP2192179A1 Cdh3 peptide and medicinal agent comprising the same |
| 06/02/2010 | EP2192176A1 Method for modifying plant morphology, biochemistry and physiology |
| 06/02/2010 | EP2192132A2 Anti-IL-20, anti-IL22 and anti-IL-22RA antibodies and binding partners and methods of using in inflammation |
| 06/02/2010 | EP2192131A1 Immunoglobulins devoid of light chains |
| 06/02/2010 | EP2192130A1 Human DR4 antibodies and uses thereof |
| 06/02/2010 | EP2192128A2 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 06/02/2010 | EP2192127A1 Haemophilus influenzae type IV Pili |
| 06/02/2010 | EP2191846A1 Method for treating pain by administering a nerve growth factor antagonist and an NSAID and composition containing the same |
| 06/02/2010 | EP2190990A1 Pthrp, its isoforms and antagonist thereto in the diagnosis and treatment of disease |
| 06/02/2010 | EP2190984A2 Method and kits for dissociating fcgamma-receptor-igg complexes and for igg purification and detection |
| 06/02/2010 | EP2190881A1 Anti-idiotypic antibodies which neutralise the inhibitory activity of an inhibitory antibody directed against the c1 domain of factor viii |
| 06/02/2010 | EP2190880A1 Cytotoxicity mediation of cells evidencing surface expression of cd9 |
| 06/02/2010 | EP2190879A1 Novel antibodies |
| 06/02/2010 | EP2190878A1 Novel methods and antibodies for treating cancer |
| 06/02/2010 | EP2190877A1 Nesfatin-1 specific antibody and the use thereof, and nesfatin specific antibody and the use thereof |
| 06/02/2010 | EP2190876A1 Antibodies against human cytomegalovirus (hcmv) |
| 06/02/2010 | EP2190875A1 Immunoglobulins directed to bacterial viral and endogenous polypeptides |
| 06/02/2010 | EP2190874A1 Insulin-like growth factor fusion proteins |
| 06/02/2010 | EP2190870A1 Cell marker of melanocyte cell lineage and uses thereof |
| 06/02/2010 | EP2190477A1 Donor specific antibody libraries |
| 06/02/2010 | EP2190468A2 Methods and compositions for modulating t cells |
| 06/02/2010 | EP1830881B1 Combining therapies targeting multiple toll-like receptors and use thereof |
| 06/02/2010 | EP1626992B1 Production of recombinant igm in per.c6 cells |
| 06/02/2010 | EP1534736B1 Nogo receptor antagonists |
| 06/02/2010 | EP1449432B1 Nonhuman model animal of systemic lupus erythematosus |
| 06/02/2010 | CN1291231B Human telomerase catalytic subunit |
| 06/02/2010 | CN101720230A Pharmaceutical composition comprising the anti-4-1bb antibody for treating or preventing rheumatoid arthritis |
| 06/02/2010 | CN101720227A Cytotoxic anti-lag-3 monoclonal antibody and its use in the treatment or prevention of organ transplant rejection and autoimmune disease |
| 06/02/2010 | CN101718788A Method for detecting apramycin and special enzyme-linked immunoassay kit thereof |
| 06/02/2010 | CN101717775A Single-chain antibody gene of anti-human death receptor 5 |
| 06/02/2010 | CN101717754A Enterovirus type 71 and use thereof |
| 06/02/2010 | CN101717448A Single-chain antibody hsIVM8 of ivermectin and preparation method and application thereof in immunology detection |
| 06/02/2010 | CN101717447A Method for preparing antihuman recombinant tissue factor monoclonal antibody |
| 06/02/2010 | CN101717446A Preparation for PRRSV-N-IgY antibody and application thereof in detecting PRRSV |
| 06/02/2010 | CN101717445A Preparing method of egg yolk antibody |
| 06/02/2010 | CN101717444A Kit for detecting melamine and application thereof |
| 06/02/2010 | CN101717443A Bensulfuron-methyl artificial immunogen BE-BSA, preparation thereof and application thereof |
| 06/02/2010 | CN101717436A Mud crab bicistronic mRNA virus structural protein 2 and monoclonal antibody thereof and application |
| 06/02/2010 | CN101717435A Mud crab bicistronic mRNA virus structural protein 3, monoclonal antibody thereof and application |
| 06/02/2010 | CN101717434A Mud crab bicistronic mRNA virus structural protein 1, monoclonal antibody thereof and application |
| 06/02/2010 | CN101717349A Preparation method and applications of intermediate modifier of Sudan red I |
| 06/01/2010 | US7728121 Nucleotide sequences coding portion of viral early gene; generating immunoglobulin for detecting viral infection |
| 06/01/2010 | US7728115 Compositions and methods useful for the diagnosis and treatment of heparin induced thrombocytopenia/thrombosis |
| 06/01/2010 | US7728114 Cluster of differentiation (CD3) specific monoclonal antibody for use in treatment and prevention of autoimmune and transplant disorders |
| 06/01/2010 | US7728113 Methods of treating arthritic conditions with antibodies to M-CSF |
| 06/01/2010 | US7728112 Kit comprising epitope specific immunoglobulin for use in diagnosis/prognosis of bone disorders; Antiarthritic agents; screenning for osteoarthritis |
| 06/01/2010 | US7728111 Anti-p55 TNF receptor antibody |
| 06/01/2010 | US7728110 Immunoglobulin specific to severe acute respiratory syndrome (SARS) corona virus for use in diagnosis, prevention and treatment of viral diseases associated with respiratory system |
| 06/01/2010 | US7728109 Antagonistic anti-hTNFSF13b human antibodies |
| 06/01/2010 | US7728108 PRO1550 polypeptides |
| 06/01/2010 | US7727956 Deoxonadepsipeptides |
| 06/01/2010 | US7727950 Methods and reagents for assaying protein kinase activity |
| 06/01/2010 | US7727741 Nucleotide sequences coding glycoengineered peptides with enhance Fc receptor binding affinity and effector function for treatment and prevention of cell proliferative disorders |
| 06/01/2010 | US7727735 Detection and treatment of prostate cancer |
| 06/01/2010 | US7727536 EG-VEGF nucleic acids and polypeptides and methods of use |
| 06/01/2010 | US7727533 Serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 06/01/2010 | US7727531 Antibodies for preventing and treating attaching and effacing Escherichia coli (AEEC) associated diseases |
| 06/01/2010 | US7727529 Hepatitis c viral E2 glycoprotein specific immunoglobulin for use in prevention and treatment of hepatitis infection |
| 06/01/2010 | US7727527 Anti-NGF antibodies for the therapeutic treatments |
| 06/01/2010 | US7727526 Use of PTHrP antagonists for treating renal cell carcinoma |
| 06/01/2010 | US7727520 Method of promoting the healing of a chronic wound |
| 06/01/2010 | CA2512040C Designed deimmunized monoclonal antibodies for protection against hiv exposure and treatment of hiv infection |
| 06/01/2010 | CA2441952C Plasmodium falciparum ama-1 protein and uses thereof |
| 06/01/2010 | CA2370666C A tenascin-c isoform as a marker for neoplasias |
| 06/01/2010 | CA2288600C A method for making multispecific antibodies having heteromultimeric and common components |
| 06/01/2010 | CA2288373C Human cerberus protein |
| 06/01/2010 | CA2219961C Vasopermeability enhancing peptide of human interleukin-2 and immunoconjugates thereof |
| 05/27/2010 | WO2010060095A1 Bispecific egfr/igfir binding molecules |
| 05/27/2010 | WO2010059821A1 Anti-unc5b antibodies and methods of use |
| 05/27/2010 | WO2010059654A1 c-MET ANTIBODIES |
| 05/27/2010 | WO2010059543A1 Generation and characterization of anti-notch antibodies for therapeutic and diagnostic use |
| 05/27/2010 | WO2010058550A1 Therapeutic or prophylactic agent for liver diseases comprising anti-human ggt antibody |
| 05/27/2010 | WO2010058396A1 A cd44vra antibody and diagnostic and therapeutic methods using same |
| 05/27/2010 | WO2010057882A2 Composition for producing anti-amyloid beta peptide antibodies with d-peptides |
| 05/27/2010 | WO2010057626A1 Deglycosylated antibodies |
| 05/27/2010 | WO2010057503A2 Long acting conserved natural functional groups curcumin |
| 05/27/2010 | WO2010038155A3 Antibodies against il-25 |